Poland· PL-100089132

Grypolek

A paracetamol, kombinationen mit psycholeptika product containing paracetamolum + guaifenesinum + pseudoephedrini hydrochloridum + dextromethorphani hydrobromidum, registered in Poland by Kato Labs Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC N02BE71

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedGrypolekATCN02BE71REGISTER NO.PL-100089132PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Paracetamol, kombinationen mit psycholeptika is registered in 2 of 19 countries.

Countries holding a registration under ATC N02BE71 (paracetamol, kombinationen mit psycholeptika), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Paracetamol, kombinationen mit psycholeptika · ATC N02BE71

2 / 19 countries

  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Paracetamolum + Guaifenesinum + Pseudoephedrini hydrochloridum + Dextromethorphani hydrobromidum
Manufacturer
Kato Labs Sp. z o.o.
Country
Poland (PL)
ATC code
N02BE71
ATC class
Paracetamol, Kombinationen mit Psycholeptika
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990439416
  • gtin
    05909990214006
  • gtin
    05909990738458
  • gtin
    05909991008321

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Paracetamol, kombinationen mit psycholeptika in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paracetamol, kombinationen mit psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee288d1f-3613-4979-b60a-cca2bb0b06f4
GET /v1/drugs/ee288d1f-3613-4979-b60a-cca2bb0b06f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "325 mg + 200 mg + 30 mg + 15 mg",
  "packaging": "05909990439416 ¦ OTC ¦ Skasowane ¦ 14274\n12 tabl. w blistrze\n05909990214006 ¦ OTC ¦ 26234\n6 tabl.\n05909990738458 ¦ OTC ¦ 53914\n12 tabl.\n05909991008321 ¦ OTC ¦ 79348\n24 tabl.",
  "substance": "Paracetamolum 325 mg + Guaifenesinum 200 mg + Pseudoephedrini hydrochloridum 30 mg + Dextromethorphani hydrobromidum 15 mg",
  "common_name": "Paracetamolum + Guaifenesinum + Pseudoephedrini hydrochloridum + Dextromethorphani hydrobromidum",
  "pl_product_id": "100089132",
  "pozwolenie_nr": "04394",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about paracetamol, kombinationen mit psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.